Literature DB >> 26933983

The Dilution Confusion: Easy Dosing for Botulinum Toxins.

Julie Bass Kaplan1.   

Abstract

Aesthetic practitioners prefer various reconstitution volumes for botulinum toxins (BoNTAs). Some injectors prefer larger volumes of bacteriostatic normal saline (NaCl) to achieve a larger diffusion in certain areas and a smaller volume for more precise administration of the BoNTA. Some practitioners believe dilution volumes do not matter at all in relation to spread or diffusion, asserting the diffusion area is simply dose-related. It can get confusing when there is more than one injector in an office, different volumes of saline, and more than one type of syringe to administer the neurotoxin. This leaves possibilities for confusion and dosage errors. This article explores four steps to take the confusion out of reconstituting BoNTAs and delivering accurate and consistent doses within a medical office.

Mesh:

Substances:

Year:  2016        PMID: 26933983     DOI: 10.1097/PSN.0000000000000121

Source DB:  PubMed          Journal:  Plast Surg Nurs        ISSN: 0741-5206


  4 in total

Review 1.  Dynamic Relaxers of the Face.

Authors:  Rashmi Shetty
Journal:  J Cutan Aesthet Surg       Date:  2018 Apr-Jun

2.  Efficacy and Safety of Botulinum Toxin Type A in Spasticity Caused by Spinal Cord Injury: A Randomized, Controlled Trial.

Authors:  Xu Yan; Jie Lan; Yancheng Liu; Jun Miao
Journal:  Med Sci Monit       Date:  2018-11-13

3.  Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines.

Authors:  Benjamin Ascher; Berthold Rzany; Philippe Kestemont; Said Hilton; Marc Heckmann; Isaac Bodokh; Ernst Magnus Noah; Dominique Boineau; Martina Kerscher; Magali Volteau; Philippe Le Berre; Philippe Picaut
Journal:  Aesthet Surg J       Date:  2020-01-01       Impact factor: 4.283

4.  The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: Key Clinical Postulates II.

Authors:  Mark S Nestor; David Arnold; Daniel Fischer
Journal:  J Cosmet Dermatol       Date:  2020-09-16       Impact factor: 2.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.